This course will explore management of patients with advanced cancer in the context of a team-based approach to care.  While palliative radiotherapy may at times be less technically complex than other forms of radiotherapy treatments, the accompanying discussions with patients and families is hig

This course will cover the management of gynecologic malignancies, concentrating on cervical (25 minutes), uterine (25 minutes), and vulvar cancers (15 minutes), with time for questions from the audience (15 minutes).  Participants will review the seminal trials and manuscripts which guide curren

In this course, the role of radiation therapy in the management of patients with extranodal non-Hodgkin’s lymphoma of the following sites: CNS, orbit and skin, will be reviewed.

Controversy exists as to the need for surgical staging in all patients. The proper application of adjuvant radiotherapy and chemotherapy also is a source of considerable debate. This educational session will review these controversies with special attention to the impact on patient care.

This session will review and update the current standard of care for pediatric sarcomas including rhabdomyosarcoma, Ewing sarcoma, and other soft tissue sarcomas. Recent and current COG trials will be highlighted.

The specific scenarios will include men with newly diagnosed localized, locally advanced, post-operative pT3,4 and/or margin + disease in the setting of an undetectable PSA in addition to post-operative or post-radiation PSA recurrence.

Experience, knowledge, and guidelines about intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) have been accumulated over the past decade, but they have largely not been formally modeled to support more efficient and optimal treatment planning and even automa

Soft tissue sarcomas present in a wide variety of locations and span a wide variety of locations. This makes the management of these tumors challenging.  However, there are a number of well-known principles that can be considered in the planning of treatment of these tumors.

This session will provide a practical overview of Oncofertility. It will discuss thescope of the risks to fertility in our younger patient population.

In the recent years, there has been a sharp increase of interest in the use of SBRT for the treatment of various primary and metastatic tumors of various organ sites.